Zemplar

Paricalcitol (Zemplar) is an intravenous vitamin D analog used to manage secondary hyperparathyroidism in chronic kidney disease. This prescription medication helps regulate calcium and phosphate levels. Suitable for patients on dialysis or with stage 3-5 CKD. Always consult a healthcare provider before use.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease. It works by reducing elevated parathyroid hormone levels, which can otherwise weaken bones and cause calcium imbalances. The medication is often prescribed when phosphate binders alone are insufficient. It may also be used in patients preparing for kidney transplant.

Paricalcitol helps restore balance to calcium and phosphate levels in the body. Patients may notice improved bone health and reduced symptoms like muscle weakness or bone pain. Some individuals experience mild gastrointestinal effects such as nausea or constipation during treatment.

Paricalcitol should be administered under medical supervision, typically in a clinical setting. Blood calcium levels must be monitored regularly to avoid hypercalcemia. Patients with a history of calcium disorders should discuss risks with their doctor. Keep this medication stored at controlled room temperature away from moisture.

Paricalcitol may interact with medications that affect calcium metabolism, such as thiazide diuretics or calcium supplements. Strong CYP3A inhibitors can increase paricalcitol levels, requiring dose adjustments. Patients should inform their healthcare provider about all prescription, over-the-counter, and herbal products they use. Avoid alcohol during treatment unless approved by a doctor.